9 research outputs found

    kD-STR : a method for spatio-temporal data reduction and modelling

    Get PDF
    Analysing and learning from spatio-temporal datasets is an important process in many domains, including transportation, healthcare and meteorology. In particular, data collected by sensors in the environment allows us to understand and model the processes acting within the environment. Recently, the volume of spatio-temporal data collected has increased significantly, presenting several challenges for data scientists. Methods are therefore needed to reduce the quantity of data that needs to be processed in order to analyse and learn from spatio-temporal datasets. In this article, we present the -Dimensional Spatio-Temporal Reduction method (D-STR) for reducing the quantity of data used to store a dataset whilst enabling multiple types of analysis on the reduced dataset. D-STR uses hierarchical partitioning to find spatio-temporal regions of similar instances, and models the instances within each region to summarise the dataset. We demonstrate the generality of D-STR with three datasets exhibiting different spatio-temporal characteristics and present results for a range of data modelling techniques. Finally, we compare D-STR with other techniques for reducing the volume of spatio-temporal data. Our results demonstrate that D-STR is effective in reducing spatio-temporal data and generalises to datasets that exhibit different properties

    Comparing motor-­vehicle crash risk of EU and US vehicles

    Full text link
    This study examined the hypotheses that vehicles meeting EU safety standards perform similarly to US-­‐regulated vehicles in the US driving environment, and vice versa. The analyses used three statistical approaches to “triangulate” evidence regarding differences in crash and injury risk. Separate analyses assessed crash avoidance technologies, including headlamps and mirrors. The results suggest that when controlling for differences in environment and exposure, vehicles meeting EU standards offer reduced risk of serious injury in frontal/side crashes and have driver-­‐side mirrors that reduce risk in lane-­‐change crashes better, while vehicles meeting US standards provide a lower risk of injury in rollovers and have headlamps that make pedestrians more conspicuous.Alliance of Automobile Manufacturershttp://deepblue.lib.umich.edu/bitstream/2027.42/112977/1/103199.pd

    Comparing motor-vehicle crash risk of EU and US vehicles

    Get PDF
    Objective: This study examined the hypotheses that passenger vehicles meeting European Union (EU) safety standards have similar crashworthiness to United States (US) -regulated vehicles in the US driving environment, and vice versa. Methods: The first step involved identifying appropriate databases of US and EU crashes that include in-depth crash information, such as estimation of crash severity using Delta-V and injury outcome based on medical records. The next step was to harmonize variable definitions and sampling criteria so that the EU data could be combined and compared to the US data using the same or equivalent parameters. Logistic regression models of the risk of a Maximum injury according to the Abbreviated Injury Scale of 3 or greater, or fatality (MAIS3+F) in EU-regulated and US-regulated vehicles were constructed. The injury risk predictions of the EU model and the US model were each applied to both the US and EU standard crash populations. Frontal, near-side, and far-side crashes were analyzed together (termed “front/side crashes”) and a separate model was developed for rollover crashes. Results: For the front/side model applied to the US standard population, the mean estimated risk for the US-vehicle model is 0.035 (sd = 0.012), and the mean estimated risk for the EU-vehicle model is 0.023 (sd = 0.016). When applied to the EU front/side population, the US model predicted a 0.065 risk (sd = 0.027), and the EU model predicted a 0.052 risk (sd = 0.025). For the rollover model applied to the US standard population, the US model predicted a risk of 0.071 (sd = 0.024), and the EU model predicted 0.128 risk (sd = 0.057). When applied to the EU rollover standard population, the US model predicted a 0.067 risk (sd = 0.024), and the EU model predicted 0.103 risk (sd = 0.040). Conclusions: The results based on these methods indicate that EU vehicles most likely have a lower risk of MAIS3+F injury in front/side impacts, while US vehicles most likely have a lower risk of MAIS3+F injury in llroovers. These results should be interpreted with an understanding of the uncertainty of the estimates, the study limitations, and our recommendations for further study detailed in the report

    No father required? The welfare assessment in the Human Fertilisation and Embryology Act 2008

    Get PDF
    Of all the changes to the Human Fertilisation and Embryology Act 1990 that were introduced in 2008 by legislation of the same name, foremost to excite media attention and popular controversy was the amendment of the so-called welfare clause. This clause forms part of the licensing conditions which must be met by any clinic before offering those treatment services covered by the legislation. The 2008 Act deleted the statutory requirement that clinicians consider the need for a father of any potential child before offering a woman treatment, substituting for it a requirement that clinicians must henceforth consider the child’s need for “supportive parenting”. In this paper, we first briefly recall the history of the introduction of s 13(5) in the 1990 Act, before going on to track discussion of its amendment through the lengthy reform process that preceded the introduction of the 2008 Act. We then discuss the meaning of the phrase “supportive parenting” with reference to guidance regarding its interpretation offered by the Human Fertilisation and Embryology Authority. While the changes to s 13(5) have been represented as suggesting a major change in the law, we suggest that the reworded section does not represent a significant break from the previous law as it had been interpreted in practice. This raises the question of why it was that an amendment that is likely to make very little difference to clinical practice tended to excite such attention (and with such polarising force). To this end, we locate debates regarding s 13(5) within a broader context of popular anxieties regarding the use of reproductive technologies and, specifically, what they mean for the position of men within the family

    Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    Get PDF
    Background: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings: Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79). Interpretation: In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

    2D-STR : reducing spatio-temporal traffic datasets by partitioning and modelling

    Get PDF
    Spatio-temporal data generated by sensors in the environment, such as traffic data, is widely used in the transportation domain. However, learning from and analysing such data is increasingly problematic as the volume of data grows. Therefore, methods are required to reduce the quantity of data needed for multiple types of subsequent analysis without losing significant information. In this paper, we present the 2-Dimensional Spatio-Temporal Reduction method (2D-STR), which partitions the spatio-temporal matrix of a dataset into regions of similar instances, and reduces each region to a model of its instances. The method is shown to be effective at reducing the volume of a traffic dataset to <5% of its original volume whilst achieving a normalise root mean squared error of <5% when reproducing the original features of the dataset

    Comparing motor-vehicle crash risk of EU and US vehicles

    No full text
    This study examined the hypotheses that vehicles meeting EU safety standards perform similarly to US-\uadregulated vehicles in the US driving environment, and vice versa. The analyses used three statistical approaches to “triangulate” evidence regarding differences in crash and injury risk. Separate analyses assessed crash avoidance technologies, including headlamps and mirrors. The results suggest that when controlling for differences in environment and exposure, vehicles meeting EU standards offer reduced risk of serious injury in frontal/side crashes and have driver‐side mirrors that reduce risk in lane-change crashes better, while vehicles meeting US standards provide alower risk of injury in rollovers and have headlamps that make pedestrians more conspicuous

    Swallows and Amazons, or the Sporting Exception To the Gender Recognition Act

    No full text
    The Gender Recognition Act 2004 purports to restrict transgendered persons’ opportunities to participate in sports if their involvement is not conducive to either ‘competitive fairness’ or ‘safety’. This article considers the difficulties in founding a prohibition on either ground, through reference to the medical literature and by considering relevant developments in other jurisdictions. It works towards a theoretical framework for consideration of the broader issues concerning sport and sexed/gendered bodies by suggesting that transgender sport may be regarded as a struggle over the legitimate use of the sporting body; and one that both reinforces and challenges the significance of sports as a gendering practice
    corecore